A new coronavirus drug is newly registered in Russia that said to ease the pain of virus patients experiencing inflammation complications. Though it is not a vaccine, this drug may treat a sick person to feel less pain during COVID-19 treatment. Until a vaccine comes into the world, this might be helpful for most infected people.
Russia has a new formulated COVID-19 drug that eases the pain of patients
Levilimab isn't the only COVID-19 drug that Russia can be proud of. A week earlier, the country also approved its first antiviral drug called Avifavir.
This drug helps to seek "high efficacy in treating patients with coronavirus during clinical trials." As reported, Avifavir can treat COVID-19 patients within four days of treatment, compared to the nine-day standard operation in most countries.
The first batch of the antiviral drug will be delivered to hospitals in Russia and will be given quickly to patients, with no charges. But, it must be used with a doctor's supervision.
